Skip to content
Megan H. Hyland, M.D.

Megan H. Hyland, M.D.

Neurology

UR Medicine Faculty The University of Rochester Medical Faculty Group (URMFG) consists of over 900 specialist and primary care providers spanning 19 departments. URMFG is certified by the National Committee for Quality Assurance.
Accountable Health Partner Accountable Health Partners (AHP) is a network of over 2,000 community and UR medical faculty and a dozen leading hospitals throughout the region. AHP offers a full range of care.
Accepting New Patients

Contact

Appointment (585) 275-7854

Locations

Neurology

601 Elmwood Avenue, 1st Floor
Rochester, NY 14642

About Me

Professional Background

Dr. Megan H. Hyland, MD, MS, is an Assistant Professor at the University of Rochester Medical Center. Dr. Hyland graduated from Rensselaer Polytechnic Institute with a degree in biomedical engineering and worked as a reliability engineer prior to attending medical school. She completed her medical...
Dr. Megan H. Hyland, MD, MS, is an Assistant Professor at the University of Rochester Medical Center. Dr. Hyland graduated from Rensselaer Polytechnic Institute with a degree in biomedical engineering and worked as a reliability engineer prior to attending medical school. She completed her medical degree, medicine internship and neurology residency at the University of Rochester, followed by a fellowship in Neuroimmunology at the Cleveland Clinic. She simultaneously received her Masters Degree in Clinical Investigation through Case Western Reserve University.

Dr. Hyland returned to Rochester in 2012 after fellowship completion and became co-Medical Director of the Rochester Multiple Sclerosis Center in 2014. In that role, she is passionate about improving access to specialized comprehensive care for patients with multiple sclerosis and similar diseases, such as neuromyelitis optica, neurosarcoidosis, and autoimmune encephalitis. Dr. Hyland is also the co-chair of the Clinical Advisory Committee for the Upstate New York Chapter of the National MS Society.

Dr. Hyland is involved in several clinical trials investigating multiple sclerosis therapies--both symptomatic treatments and therapies designed to slow or halt disease progression. She is evaluating the use of telemedicine as an alternate means of providing care to MS patients. Her research interests also include epidemiological studies in MS and analysis of large patient databases to answer clinical questions not easily assessed through clinical trials.

Certified Specialties

Neurology - American Board of Psychiatry & Neurology

Faculty Appointments

Associate Professor (Part-Time) - Department of Neurology, Neuroimmunology (SMD)

Credentials

Residency & Fellowship

Fellowship, Cleveland Clinic Foundation. 2010 - 2012

Residency, Neurology, University of Rochester Medical Center. 2007 - 2010

Internship, Internal Medicine, University of Rochester Medical Center. 2006 - 2007

Education

MD | University of Rochester School of Medicine/Dentistry. 2006

Awards

National MS Society Professional on the Move. 2016

Edward T Mulligan, MD Memorial Award. 2010

Leopold L Balleisen Prize. 2001

Paul B Daitch Memorial Award. 2001

Publications

Journal Articles

Agreement Between Published Reference Resources for Neurofilament Light Chain Levels in People With Multiple Sclerosis.

Sotirchos ES, Hu C, Smith MD, Lord HN, DuVal AL, Arrambide G, Montalban X, Akgün K, Ziemssen T, Naismith RT, Hersh CM, Hyland M, Krupp LB, Nicholas JA, Bermel RA, Mowry EM, Calabresi PA, Fitzgerald KC

Neurology.. 2023 October 10 Epub 10/10/2023.

Associations of sNfL with clinico-radiological measures in a large MS population.

Sotirchos ES, Fitzgerald KC, Singh CM, Smith MD, Reyes-Mantilla M, Hersh CM, Hyland MH, Canissario R, Simmons SB, Arrambide G, Montalban X, Comabella M, Naismith RT, Qiao M, Krupp LB, Nicholas JA, Akgün K, Ziemssen T, Rudick R, Fisher E, Bermel RA, Mowry EM, Calabresi PA

Annals of clinical and translational neurology.. 2022 November 25 Epub 11/25/2022.

Immunoglobulin G immune response to SARS-CoV-2 vaccination in people living with multiple sclerosis within Multiple Sclerosis Partners Advancing Technology and Health Solutions.

Cohen JA, Bermel RA, Grossman CI, Hersh CM, Hyland M, Mowry EM, Naismith R, Naylor ML, Nicholas J, Rajbhandar R, Singh CM, Tintorè M, Zabalza A, Ziemssen T, Williams JR, Montalban X

Multiple sclerosis : clinical and laboratory research.. 2022 June 28 (7):1131-1137. Epub 01/07/2022.

Effects of Ibudilast on MRI Measures in the Phase 2 SPRINT-MS Study.

Naismith RT, Bermel RA, Coffey CS, Goodman AD, Fedler J, Kearney M, Klawiter EC, Nakamura K, Narayanan S, Goebel C, Yankey J, Klingner E, Fox RJ,

Neurology.. 2021 January 2696 (4):e491-e500. Epub 12/02/2020.

Treating MS after surviving PML: Discrete strategies for rescue, remission, and recovery patient 1: From the National Multiple Sclerosis Society Case Conference Proceedings.

Anadani N, Hyland M, Cruz RA, Lisak R, Costello K, Major EO, Jassam Y, Meltzer E, Varkey TC, Parsons MS, Goodman AD, Graves JS, Newsome S, Zamvil SS, Frohman EM, Frohman TC

Neurology® neuroimmunology & neuroinflammation.. 2021 January 8 (1)Epub 12/15/2020.

Impact of natalizumab on quality of life in a real-world cohort of patients with multiple sclerosis: Results from MS PATHS.

Hersh CM, Kieseier B, de Moor C, Miller DM, Campagnolo D, Williams JR, Fitzgerald KC, Xiong K, McGinley MP, Hyland M, Rudick RA, Ziemssen T, Koulinska I

Multiple sclerosis journal - experimental, translational and clinical.. 2021 7 (2):20552173211004634. Epub 04/15/2021.

The impact of cognitive rehabilitation on quality of life in multiple sclerosis: A pilot study.

Munger KC, Martinez AP, Hyland MH

Multiple sclerosis journal - experimental, translational and clinical.. 2021 7 (3):20552173211040239. Epub 08/26/2021.

Teleconsultation will replace most face-to-face interactions in the multiple sclerosis clinic - Yes.

Hyland MH, Robb JF

Multiple sclerosis : clinical and laboratory research.. 2020 December 16 :1352458520973640. Epub 12/16/2020.

Socioeconomic status and race are correlated with affective symptoms in multiple sclerosis.

Wang Y, Tian F, Fitzgerald KC, Bhattarai JJ, Naismith RT, Hyland M, Calabresi PA, Mowry EM

Multiple sclerosis and related disorders.. 2020 June 41 :102010. Epub 02/14/2020.

Harnessing Real-World Data to Inform Decision-Making: Multiple Sclerosis Partners Advancing Technology and Health Solutions (MS PATHS).

Mowry EM, Bermel RA, Williams JR, Benzinger TLS, de Moor C, Fisher E, Hersh CM, Hyland MH, Izbudak I, Jones SE, Kieseier BC, Kitzler HH, Krupp L, Lui YW, Montalban X, Naismith RT, Nicholas JA, Pellegrini F, Rovira A, Schulze M, Tackenberg B, Tintore M, Tivarus ME, Ziemssen T, Rudick RA

Frontiers in neurology. 2020 11 :632. Epub 08/07/2020.

Comparison of telemedicine versus in-person visits for persons with multiple sclerosis: A randomized crossover study of feasibility, cost, and satisfaction.

Robb JF, Hyland MH, Goodman AD

Multiple sclerosis and related disorders.. 2019 May 636 :101258. Epub 05/06/2019.

Restricted diffusion preceding gadolinium enhancement in large or tumefactive demyelinating lesions.

Hyland M, Bermel RA, Cohen JA

Neurology. Clinical practice.. 2013 February 3 (1):15-21. Epub 1900 01 01.

Multiple sclerosis: new insights in pathogenesis and novel therapeutics.

Ontaneda D, Hyland M, Cohen JA

Annual review of medicine.. 2012 63 :389-404. Epub 09/01/2011.

Fingolimod.

Hyland MH, Cohen JA

Neurology. Clinical practice.. 2011 December 1 (1):61-65. Epub 1900 01 01.

Challenges to clinical trials in multiple sclerosis: outcome measures in the era of disease-modifying drugs.

Hyland M, Rudick RA

Current opinion in neurology.. 2011 June 24 (3):255-61. Epub 1900 01 01.

Pearls & Oy-sters: a stroke of luck: detecting type A aortic dissection by MRA.

Hyland MH, Holloway RG

Neurology.. 2011 February 2276 (8):e31-3. Epub 1900 01 01.

Ratings & Reviews

At URMC, we believe that patients should be empowered to make the right decisions regarding their personal healthcare. To do so, transparency is critical. URMC partners with Press Ganey, to survey our patients about all aspects of their care experience. We are now putting this pertinent information at your fingertips by displaying star ratings for our providers along with anonymous patient comments on our website. This will help you make better-informed choices about how and with whom you seek care. Click here to learn more about the surveys used to generate this vital information. Learn more about our survey process.